Author

A. Mengozzi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

A. De Carli· 2 shared C. Filipponi· 2 shared E. Iacono· 2 shared F. Fornai· 2 shared G. Freer· 2 shared M. Lai· 2 shared M. Pistello· 2 shared P. Lenzi· 2 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. De Carli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Chromatin Remodeling by the Histone Methyltransferase SETD2 Drives Lipotoxic Injury in Cardiometabolic Heart Failure with Preserved Ejection Fraction

S. Ambrosini, S. Costantino, S. A. Mohammed, E. Gorica, M. Herwig, L. van Heerebeek, A. Mengozzi, G. Karsai, T. Hornemann, O. Dzemali, F. Ruschitzka, N. Hamdani, F. Paneni

This study shows that SETD2 promotes lipotoxic injury in cHFpEF by regulating SREBP1 and lipid metabolism, and its inhibition improves cardiac function.

bioRxiv · Jul 25, 2024 · PreprintPhysiology

N-acylethanolamine acid amidase inhibition reduces SARS-CoV-2 infection in Human Precision cut-lung slices and downregulates NF-kappaB signalling.

V. La Rocca, C. Filipponi, V. Diesendorf, A. De Carli, G. Sciandrone, S. Nottoli, E. Plicanti, R. Fonnesu, E. Iacono, A. Mengozzi, S. Masi, P. Lenzi, F. Fornai, K. Sewald, H. Obernolte, , M. Lai

This study shows that inhibiting NAAA reduces SARS-CoV-2 replication in human lung tissue and suppresses NF-kappaB signaling.

bioRxiv · Jul 10, 2024 · PreprintMicrobiology

N-acylethanolamine acid amide hydrolase is a novel target for drugs against SARS-CoV-2 and Zika virus

M. Lai, V. La Rocca, R. Amato, E. Iacono, c. filipponi, E. Catelli, L. Bogani, R. Fonnesu, g. lottini, A. De Carli, A. Mengozzi, S. Masi, P. Quaranta, P. G. Spezia, G. Freer, , M. Pistello

This paper shows that inhibiting NAAA reduces SARS-CoV-2 and ZIKV replication and inflammation in cell lines and human PBMCs.

bioRxiv · Feb 8, 2022 · PreprintMicrobiology